2nd Quarter - Report

VENN STRATEGIES for ELI LILLY AND COMPANY

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

General tax issues pertaining to Eli Lilly, including but not limited to tax reform.

LobbyistCovered position, as disclosed
NATASCHA CUMBERLIDGE —
CLAIRE ONYECHI New U.S. Senate, Office of the Democratic Leader, Democratic Steering and Outreach Committee
AUSTIN TYLER ROBERTS —
STEPHANIE SILVERMAN —
MICHAEL SPIRA —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation and innovation policies.

LobbyistCovered position, as disclosed
NATASCHA CUMBERLIDGE —
CLAIRE ONYECHI New U.S. Senate, Office of the Democratic Leader, Democratic Steering and Outreach Committee
AUSTIN TYLER ROBERTS —
STEPHANIE SILVERMAN —
MICHAEL SPIRA —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.